The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (4 analysts) rates it none, with a mean price target of $5.
Evolution Petroleum Corp
EPM · NYSE AMERICAN · USD · Market cap $158M · 11 employees
Evolution Petroleum Corporation, an energy company, engages in the development, production, ownership, exploitation, and investment of onshore oil and gas properties in the United States.
PASS · Titan Ethical · score 70.0Price as of 3 Nov 2026Daily close, not a live quote
Screened 2026-11-03 · the tape above runs as of 10:13 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price3.65 USD at the 3 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 3 Nov 2026
- Our regime readAccumulation, as of 3 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- Last reviewed3 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $2.80 to $3.22, base estimate $2.80 (screen dated 2026-11-03).
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
Evolution Petroleum Corp holds its Accumulation at $3.65. The statistical read favours the sellers, held for 31 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the sellers, held for 31 days |
| Price at the screen | $3.65 |
| Valuation | N/A trailing · 39.30 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.48 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 23.44% | Below 33% | Interest-bearing debt is just 23.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 8.31% | Below 49% | Money owed to the company is 8.3% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.22% | Below 5% | Only 0.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Evolution Petroleum clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 23%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when EPM's ethical verdict changes
Today EPM passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 3 Nov 2026: it trades above our $2.80 fair value estimate, none competitive moat, 14.70% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-03 screen. The gold marker is the market price at the same screen. The price runs 30.4% above the base estimate.
Third-party analyst targets: 4 covering, consensus Strong Buy. The average target sits +30% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $2.80, with a range of $2.80 to $3.22, dated to the 2026-11-03 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it gives us pause
At 39.3x forward earnings, the price already runs ahead of the business. It trades 31% above our $2.80 fair value, so you would be buying at a premium, not a discount. The none moat is real, but quality alone does not make an expensive price cheap.
| Forward P/E | 39.3xexpensive even after accounting for its growth |
| EPS, trailing | -0.08 |
| EPS, forward | 0.10 |
| Revenue growth | +14.7%steady growth |
| Profit margin | -2.8%currently unprofitable |
| Return on equity | -3.7%not currently earning a positive return on equity |
| FCF yield | -3.53% |
| Dividend yield | 1,154.00% |
| Debt to equity | 0.94moderate, manageable leverage |
| Current ratio | 0.92below 1: short-term bills exceed liquid assets |
| Beta | 0.48barely tracks the market's swings |
| Short interest, float | 0.08% |
| 52-week range | 3.19 - 4.99 |
| Moat | NONE |
| Market cap | $158M |
| Employees | 11 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeEPM trades on NYSE AMERICAN. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (4 analysts) rates it none, with a mean price target of $5.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (4 analysts) rates it none, with a mean price target of $5.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (4 analysts) rates it none, with a mean price target of $5.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (4 analysts) rates it none, with a mean price target of $5.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 8.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (4 analysts) rates it none, with a mean price target of $5.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (4 analysts) rates it none, with a mean price target of $5.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Diamondback Energy Reports Soon: How Has The Stock Reacted To Past Earnings? Yahoo Finance · 5d ago
- Evolution Petroleum Schedules Fiscal First Quarter 2027 Earnings Release and Conference Call Yahoo Finance · 6d ago
- Was The Run In Devon Energy Stock Hiding In Plain Sight? Yahoo Finance · 9d ago
- Evolution Petroleum Eyes Dividend Growth With Midland Royalty Deal Yahoo Finance · 30d ago
- Evolution Petroleum Bets on Midland Royalties to Bolster Cash Flow and Dividend Yahoo Finance · 28 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $4.78 | -9.1% | · | $909 | -9.1% |
| 2 months | $4.44 | -2.1% | · | $979 | -2.1% |
| 3 months | $4.64 | -6.3% | $0.12 | $963 | -3.7% |
| 6 months | $3.85 | +12.9% | $0.24 | $1,191 | +19.1% |
| 1 year | $4.53 | -4.2% | $0.48 | $1,064 | +6.4% |
| 2 years | $4.60 | -5.6% | $0.96 | $1,153 | +15.3% |
| 3 years | $6.32 | -31.3% | $1.44 | $915 | -8.5% |
| 5 years | $3.43 | +26.8% | $2.20 | $1,910 | +91.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever EPM does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.